TNFA Bathi mangsa ngarep TNF Pharmaceuticals, Inc.

Simbol resmi perusahaan TNF Pharmaceuticals Inc. (TNFA)

TNF Pharmaceuticals is recruiting experts in rare pathologies, relying on external investor capital while gastrointestinal drug tests remain ongoing. Current consensus forecast trends demonstrate a promising financial outlook, where the mark reflects the latest data. However, its startup status creates risks due to a lack of sales and a dependence on new equity issuances to fund R&D.

TNF Pharmaceuticals (TNFA): Bathi resik sing dikarepake saka 04.07.2022 nganti 17.11.2026

TNF Pharmaceuticals Inc. - rincian analitis lan metrik utama (TNFA)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:TNFA, TNF Pharmaceuticals Inc.
Produk dadi TNF Pharmaceuticals, Inc.

The market evaluates the potential of TNF Pharmaceuticals (TNFA) through the lens of its bioinformatics development efficiency. This metric aggregates expected net income, reflecting the market consensus regarding the business's future profitability. By analyzing the company's earnings forecast history, investors can see the impact of protein design automation on reducing operating expenses. The stability of the curve confirms the scalability of robotic testing. The growth of this indicator suggests that the company is increasing its resilience to regulatory risks.

Analisis pesaing TNF Pharmaceuticals

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Bathi resik sing dikarepake|PRGO: Bathi mangsa ngarep|Alvotech SA - Bathi resik mangsa ngarep|LQDA: Proyeksi bathi mangsa ngarep|Galapagos Genomics - Penghasilan resik sing dikarepake|ANIP (ANI Pharmaceuticals Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake mannkindcorp.com MNKD|Bathi sing dikarepake Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SPRY (ARS Pharmaceuticals Inc)|Bathi resik mangsa ngarep TBPH (Theravance)|AQST - Bathi sing dikarepake|scPharmaceuticals (SCPH) - Bathi mangsa ngarep|TECX: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik TNXP|Bathi sing dikarepake China SXT Pharmaceuticals, Inc.|EPRX: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep BHST|EXOZ - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ORMP (oramed.com)|Proyeksi bathi mangsa ngarep enterabio.com ENTX|HYFT - Bathi sing dikarepake|Prakiraan bathi perusahaan ABVC BioPharma, Inc ABVC|CPIX: Proyeksi bathi mangsa ngarep|Quantum BioPharma Ltd - Penghasilan resik sing dikarepake|Bathi mangsa ngarep FGEN|Telomir Pharmaceuticals, Inc. - Bathi forward|Proyeksi bathi mangsa ngarep RANI|SNYR (Synergy CHC) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Rallybio RLYB|Lexaria Bioscience (LEXX) - Bathi resik sing dikarepake|PULM - Bathi sing dikarepake|Prakiraan bathi perusahaan Pheton Holdings PTHL|APM (Aptorum) - Bathi mangsa ngarep|Lyra Therapeutics, Inc. (LYRA) - Proyeksi bathi mangsa ngarep|IBO (impactbiomedinc.com) - Proyeksi bathi mangsa ngarep|Prakiraan bathi resik YCBD (cbdmd.com)|Bathi mangsa ngarep PRFX (PainReform Ltd)|CYTO: Bathi forward|Proyeksi bathi mangsa ngarep LIPO (lipella.com)|Bathi resik mangsa ngarep OPTN (OptiNose Corp)|PIRS: Bathi mangsa ngarep|PROC - Proyeksi bathi mangsa ngarep|PTPI: Proyeksi bathi mangsa ngarep|Qilian International Holding Group (QLI) - Proyeksi bathi mangsa ngarep|SLRN (ACELYRIN, Inc.) - Proyeksi bathi mangsa ngarep|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan